MedKoo Cat#: 574756 | Name: Isoanastrozole

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Isoanastrozole is an aromatase inhibitor which may be used as an anti-neoplastic.

Chemical Structure

Isoanastrozole
Isoanastrozole
CAS#120511-92-4

Theoretical Analysis

MedKoo Cat#: 574756

Name: Isoanastrozole

CAS#: 120511-92-4

Chemical Formula: C17H19N5

Exact Mass: 293.1640

Molecular Weight: 293.37

Elemental Analysis: C, 69.60; H, 6.53; N, 23.87

Price and Availability

Size Price Availability Quantity
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Anastrozole EP Impurity G; Isoanastrozole
IUPAC/Chemical Name
α1,α1,α3,α3-Tetramethyl-5-(4H-1,2,4-triazol-4-ylmethyl)-1,3-benzenediacetonitrile
InChi Key
UHMBCUNKPNNBSD-UHFFFAOYSA-N
InChi Code
InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-11-20-21-12-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3
SMILES Code
N#CC(C)(C)C1=CC(CN2C=NN=C2)=CC(C(C)(C)C#N)=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 293.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Behan LA, Amir E, Casper RF. Aromatase inhibitors for prevention of breast cancer in postmenopausal women: a narrative review. Menopause. 2015;22(3):342-350. doi:10.1097/GME.0000000000000426 2. Howell A. New developments in the treatment of postmenopausal breast cancer. Trends Endocrinol Metab. 2005;16(9):420-428. doi:10.1016/j.tem.2005.09.003 3. Markopoulos CJ. Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials. Cancer Metastasis Rev. 2010;29(4):581-594. doi:10.1007/s10555-010-9248-x